Can the Attorney General and DEA continue Schedule 1 placement of Cannabis now that it has 'accepted medical use' in 33 States, the District of Columbia and the National Academies of Sciences?

QUESTIONS PRESENTED 1. Can the Attorney General and DEA continue Schedule 1 placement of Cannabis now that it has “accepted medical use” in 33 States, the District of y Columbia and the National Academies of Sciences? 2. Did the Court of Appeals err by granting deference to DEA’s decision to limit witness testimony in spite of an ongoing pattern of witness tampering? 3. Did the Court of Appeals err by denying Krumm’s Motion for Writ of Mandamus ordering the DEA to exempt Cannabis from federal control under the CSA? :